We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $34.9B
1-Year Est. Return 18.88%
This Fund
S&P 500
This Quarter Est. Return
+8.77%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$12.4B
AUM Growth
+$1.23B
Cap. Flow
+$420M
Cap. Flow %
3.39%
Top 10 Hldgs %
17.91%
Holding
1,607
New
193
Increased
600
Reduced
460
Closed
133

Sector Composition

Rank Sector Weight
1 Healthcare 18.3%
2 Technology 16.24%
3 Financials 13.61%
4 Industrials 11.16%
5 Consumer Discretionary 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITA icon
226
iShares US Aerospace & Defense ETF
ITA
$14.2B
$9.96M 0.08%
132,558
+50
+0% +$3.68K
ORCL icon
227
Oracle
ORCL
$374B
$9.85M 0.08%
224,300
-12,695
-5% -$529K
RTX icon
228
RTX Corp
RTX
$290B
$9.85M 0.08%
139,146
+2,939
+2% +$206K
IRT icon
229
Independence Realty Trust
IRT
$3.92B
$9.67M 0.08%
1,052,011
+6,561
+0.6% +$59.9K
PAA icon
230
Plains All American Pipeline
PAA
$17.3B
$9.54M 0.08%
297,519
+8,920
+3% +$282K
SHAK icon
231
Shake Shack
SHAK
$2.53B
$9.49M 0.08%
264,901
+50,500
+24% +$1.75M
PRLB icon
232
Protolabs
PRLB
$1.79B
$9.44M 0.08%
174,568
-7,656
-4% -$405K
IWF icon
233
iShares Russell 1000 Growth ETF
IWF
$121B
$9.38M 0.08%
331,260
-9,504
-3% -$264K
MCHP icon
234
Microchip Technology
MCHP
$40.3B
$9.38M 0.08%
254,772
-6,334
-2% -$223K
GSK icon
235
GSK
GSK
$104B
$9.34M 0.08%
177,450
+70,740
+66% +$3.59M
ILMN icon
236
Illumina
ILMN
$31B
$9.3M 0.08%
56,342
-9,742
-15% -$1.53M
HLT icon
237
Hilton Worldwide
HLT
$72.1B
$9.23M 0.07%
161,342
+2,937
+2% +$171K
WPZ
238
DELISTED
Williams Partners L.P.
WPZ
$9.11M 0.07%
225,698
+2,246
+1% +$90.3K
PKOH icon
239
Park-Ohio Holdings
PKOH
$575M
$8.95M 0.07%
+200,527
New +$8.28M
CLR
240
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$8.89M 0.07%
195,658
-3,825
-2% -$180K
TEL icon
241
TE Connectivity
TEL
$59.6B
$8.81M 0.07%
118,153
-5,113
-4% -$376K
UN
242
DELISTED
Unilever NV New York Registry Shares
UN
$8.81M 0.07%
177,786
+4,281
+2% +$192K
BMRN icon
243
BioMarin Pharmaceuticals
BMRN
$11.6B
$8.79M 0.07%
99,961
-581
-0.6% -$51.7K
KHC icon
244
Kraft Heinz
KHC
$30.7B
$8.64M 0.07%
94,499
-16,421
-15% -$1.48M
FIS icon
245
Fidelity National Information Services
FIS
$23.1B
$8.62M 0.07%
105,952
+66,011
+165% +$5.31M
VTI icon
246
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$8.61M 0.07%
70,824
+4,924
+7% +$590K
ABCO
247
DELISTED
Advisory Board Co
ABCO
$8.41M 0.07%
185,673
-2,726
-1% -$120K
CAVM
248
DELISTED
Cavium, Inc.
CAVM
$8.32M 0.07%
126,261
+44,412
+54% +$2.97M
G icon
249
Genpact
G
$5.96B
$7.96M 0.06%
321,555
-534,847
-62% -$13M
DEO icon
250
Diageo
DEO
$49B
$7.86M 0.06%
68,044
-1,588
-2% -$178K

Similar funds

William Blair & Company's Q1 2017 Portfolio in Review

As of Q1 2017, William Blair & Company held 1,607 positions worth $12.4B, up 11% from $11.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

William Blair & Company deployed $420M of net new capital in Q1 2017, opening 193 new positions and adding to 600 existing holdings. Its largest new stake was Park-Ohio Holdings: 200,527 shares worth $8.95M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Idexx Laboratories, an estimated $32.3M trimmed.

  • William Blair & Company's largest Q1 2017 buy was Park-Ohio Holdings: 200,527 shares worth $8.95M.
  • William Blair & Company added most to Wabtec in Q1 2017, an estimated $31.4M increase.
  • William Blair & Company's biggest Q1 2017 reduction was Idexx Laboratories, cutting an estimated $32.3M.
  • William Blair & Company fully exited Hennessy Capital Acquisition Corp. Unit in Q1 2017, selling an estimated $5.55M.
  • William Blair & Company's ten largest holdings make up 18% of its $12.4B portfolio in Q1 2017.
  • William Blair & Company opened 193 new positions and closed 133 in Q1 2017.
  • William Blair & Company's portfolio value rose 11% quarter-over-quarter to $12.4B.

Based on William Blair & Company's 13F filing for Q1 2017, filed 10 May 2017.